AMERSHAM
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AMERSHAM Trademark

Serial Number: 76410122 • Registration: 2807878

AMERSHAM is a trademark filed by GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD on May 20, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD (16 trademarks)

Amersham Place, Little Chalfont
Buckinghamshire HP79NA , GB

Entity Type: 99

GE HEALTHCARE LIMITED (94 trademarks)

AMERSHAM PLACE LITTLE CHALFONT
BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 99

AMERSHAM PLC (44 trademarks)

BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 03

Trademark Details

Filing Date

May 20, 2002

Registration Date

January 27, 2004

Published for Opposition

November 4, 2003

Goods & Services

[ Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research and for nuclear cardiology and medical imaging, for use by laboratories, pharmacies, doctors, hospitals, and medical service providers; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely, automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus for manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; laboratory vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods ]

[ Diagnostic agents, preparations and substances for medical purposes; Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials and cartridges containing medical diagnostic reagents or saline solution; and radioisotope brachytherapy substances ]

Chemicals, biochemicals and reagents for use in industry, science and research, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, markers for DNA/RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase chain reaction, PCR, process and the rolling circle amplification (RCA) process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, detecting sequencing and fragment analysis of nucleic acids, proteins, and custom synthesis; reagents for recombinant protein expression purification, chromatography media; electrophoresis; spectrophotometry and fluorometry; [ radiochemicals; scintillation assays; and high through put screening assays for drug development; and chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances; chemical test reagents, saline solution and reagent-coated paper, all for scientific and laboratory use; fissionable chemical elements; radioactive elements and isotopes for industrial, scientific, and research purposes; radioactive sources and standards for use in radiographic techniques; radioactive sources for use in non-destructive testing, purification or sterilizing techniques for use in industry, science and research; chemical preparations, kits and reagents for analysis or diagnosis used for scientific purposes, namely, cell separation and culture; ] nucleic acid purification [ ; and radionuclides, gases and gas mixtures for industrial, scientific, and research purposes ]

[ Medical diagnostic services; medical imaging services; providing medical and medical product information to pharmaceutical companies and medical professionals ]

[ Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, comprised of medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; diagnostic and test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; needles and syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes; and parts and fittings for the aforesaid goods ]

[ Advisory services for pharmaceutical companies in the field of purification and chromatography; research and development services in the field of pharmaceutical and life sciences; research and product development for others, namely, research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; consultancy services relating to chemical and pharmaceutical research; analytical services in the fields of medicine, pharmaceuticals and biochemistry; radiolableling services, namely, isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 26, 2024 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Apr 26, 2024 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 26, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 26, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 28, 2023 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2023 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Sep 22, 2023 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 22, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 22, 2023 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 27, 2023 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 7, 2020 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jul 28, 2014 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 28, 2014 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Jul 28, 2014 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Jul 28, 2014 8PRT
TEAS SECTION 8 & 9 RECEIVED
Jul 24, 2014 E89R
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 11, 2010 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 10, 2010 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Feb 2, 2010 815F
TEAS SECTION 8 & 15 RECEIVED
Feb 2, 2010 E815
CASE FILE IN TICRS
Jun 7, 2007 CFIT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2005 REAP
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2004 R.PR
PUBLISHED FOR OPPOSITION
Nov 4, 2003 PUBO
NOTICE OF PUBLICATION
Oct 15, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Jun 24, 2003 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 16, 2003 ZZZX
Sec. 1(B) CLAIM DELETED
Mar 21, 2003 1.BD
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2003 CRFA
PAPER RECEIVED
Jan 28, 2003 MAIL
NON-FINAL ACTION MAILED
Dec 6, 2002 CNRT
EXAMINERS AMENDMENT MAILED
Nov 27, 2002 CNEA
NON-FINAL ACTION MAILED
Aug 27, 2002 CNRT